LU79694A1 - Procede de preparation de 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidine-4-ones - Google Patents
Procede de preparation de 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidine-4-onesInfo
- Publication number
- LU79694A1 LU79694A1 LU79694A LU79694A LU79694A1 LU 79694 A1 LU79694 A1 LU 79694A1 LU 79694 A LU79694 A LU 79694A LU 79694 A LU79694 A LU 79694A LU 79694 A1 LU79694 A1 LU 79694A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- tetrazol
- pyrido
- pyrimidine
- ones
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/800,264 US4122274A (en) | 1977-05-25 | 1977-05-25 | 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU79694A1 true LU79694A1 (fr) | 1979-02-02 |
Family
ID=25177928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU79694A LU79694A1 (fr) | 1977-05-25 | 1978-05-23 | Procede de preparation de 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidine-4-ones |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4122274A (ru) |
| JP (1) | JPS6050197B2 (ru) |
| AT (1) | AT365187B (ru) |
| AU (1) | AU521211B2 (ru) |
| BE (1) | BE867295A (ru) |
| CA (1) | CA1098520A (ru) |
| CH (1) | CH642656A5 (ru) |
| CY (1) | CY1218A (ru) |
| DE (1) | DE2822544A1 (ru) |
| DK (1) | DK160279C (ru) |
| FI (1) | FI64594C (ru) |
| FR (1) | FR2401159A1 (ru) |
| GB (1) | GB1596476A (ru) |
| GR (1) | GR71887B (ru) |
| HK (1) | HK25884A (ru) |
| IE (1) | IE46849B1 (ru) |
| IT (1) | IT1105040B (ru) |
| KE (1) | KE3357A (ru) |
| LU (1) | LU79694A1 (ru) |
| MY (1) | MY8500305A (ru) |
| NL (1) | NL190702C (ru) |
| NO (1) | NO150361C (ru) |
| SE (1) | SE437830B (ru) |
| SG (1) | SG73383G (ru) |
| YU (2) | YU42163B (ru) |
| ZA (1) | ZA782816B (ru) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU173438B (hu) * | 1975-11-27 | 1979-05-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom |
| US4495189A (en) * | 1975-11-27 | 1985-01-22 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. | Condensed pyrimidines |
| HU180439B (en) * | 1977-12-29 | 1983-03-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing 9-amino-pyrido-square bracket-1,2-a-square bracket closed-pyrimidine derivatives |
| US4192944A (en) * | 1978-04-03 | 1980-03-11 | Bristol-Myers Company | Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents |
| US4491587A (en) * | 1978-05-05 | 1985-01-01 | Mead Johnson & Company | Tetrazole derivatives |
| US4223031A (en) * | 1978-05-05 | 1980-09-16 | Mead Johnson & Company | Azolopyrimidinones |
| US4282360A (en) * | 1979-10-12 | 1981-08-04 | Hoffmann-La Roche Inc. | 7-Methylthio or methylsulfinyl-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid |
| US4419357A (en) * | 1982-01-18 | 1983-12-06 | The Dow Chemical Company | 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones |
| US4507477A (en) * | 1982-09-09 | 1985-03-26 | Riker Laboratories, Inc. | Process for tetrazolyl-pyrimidinone derivatives |
| US4476130A (en) * | 1982-09-09 | 1984-10-09 | Riker Laboratories, Inc. | 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity |
| US4474953A (en) * | 1982-09-09 | 1984-10-02 | Riker Laboratories, Inc. | Process and intermediates for the preparation of 3(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-ones |
| US4457932A (en) * | 1983-07-22 | 1984-07-03 | Bristol-Myers Company | Anti-ulcer agents |
| CA1283411C (en) * | 1985-09-25 | 1991-04-23 | Masami Doteuchi | 9-(substituted thio)-4h-pyrido[1,2-a]-pyrimidin-4-one derivatives |
| JPS63183581A (ja) * | 1985-10-03 | 1988-07-28 | Tokyo Tanabe Co Ltd | ピリド〔１，２−ａ〕ピリミジン誘導体、その製造法及びそれを有効成分とするアレルギ−疾患治療薬 |
| JPS62242682A (ja) * | 1986-04-16 | 1987-10-23 | Tokyo Tanabe Co Ltd | 新規なピリド［１，２―ａ］ピリミジン誘導体及びその製造法 |
| JP2504788B2 (ja) * | 1987-11-10 | 1996-06-05 | 東京田辺製薬株式会社 | ９−メチル−３−（１Ｈ−テトラゾ―ル−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンカリウム塩の水性製剤 |
| KR920002329B1 (ko) * | 1987-12-25 | 1992-03-21 | 산뗑 세이야꾸 가부시끼가이샤 | 항-알레르기성 점안제 |
| CA2010336C (en) * | 1989-02-27 | 1996-11-19 | Atsunori Sano | Process for producing pyrido[1,2-a]pyrimidine derivative |
| HU209793B (en) * | 1990-09-25 | 1994-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for the production of pyrido[1,2-a]pyrimidine-derivatives and pharmaceutical compositions containing the same |
| CA2138957A1 (en) | 1992-07-30 | 1994-02-17 | Shigeki Omura | A remedy for inflammatory intestinal diseases |
| US5527802A (en) * | 1992-10-01 | 1996-06-18 | Bristol-Myers Squibb Company | New uses of 3-tetrazolo -5,6,7,8- substituted-pyrido (1,2-a) pyrimidin-4-ones |
| JPH0892093A (ja) * | 1994-11-10 | 1996-04-09 | Tokyo Tanabe Co Ltd | ９−メチル−３−（１Ｈ−テトラゾール−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンの水性製剤 |
| JP4171303B2 (ja) * | 2001-02-26 | 2008-10-22 | 田辺三菱製薬株式会社 | 腎疾患・腎不全の予防剤及び／又は治療剤 |
| ITMI20011764A1 (it) * | 2001-08-10 | 2003-02-10 | Dinamite Dipharma Spa | Metodo per l'ottenimento del pemirolast ad elevata purezza |
| GB0316546D0 (en) | 2003-07-15 | 2003-08-20 | Novartis Ag | Process for the manufacture of organic compounds |
| DK2120919T3 (da) * | 2006-12-18 | 2012-11-26 | Cardoz Ab | Ny kombination til anvendelse ved behandling af inflammatoriske lidelser |
| AU2007336077A1 (en) * | 2006-12-20 | 2008-06-26 | Cardoz Ab | New combination for use in the treatment of inflammatory disorders |
| WO2009007675A2 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist |
| EP2175845A2 (en) * | 2007-07-11 | 2010-04-21 | Cardoz AB | New combination for use in the treatment of inflammatory disorders |
| WO2009007679A2 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist |
| US20110092463A1 (en) * | 2008-04-07 | 2011-04-21 | Johan Raud | Combination for use in the treatment of inflammatory disorders |
| SI2443120T1 (sl) * | 2009-06-16 | 2017-04-26 | Rspr Pharma Ab | Kristalna oblika pemirolasta |
| USD661900S1 (en) | 2010-02-22 | 2012-06-19 | Bajer Design & Marketing, Inc. | Collapsible structure |
| EP3406252B1 (en) | 2012-02-10 | 2020-05-13 | PTC Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
| EA029155B1 (ru) | 2012-03-01 | 2018-02-28 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Соединения для лечения спинальной мышечной атрофии |
| CN104470909B (zh) | 2012-03-23 | 2018-04-24 | Ptc医疗公司 | 用于治疗脊髓性肌萎缩的化合物 |
| EP3082820B1 (en) | 2013-12-19 | 2022-07-20 | PTC Therapeutics, Inc. | Methods for modulating the amount of rna transcripts |
| US20160243122A1 (en) | 2014-10-23 | 2016-08-25 | Rspr Pharma Ab | Use of pemirolast in the treatment of acute asthma |
| WO2016102941A1 (en) | 2014-12-22 | 2016-06-30 | Rspr Pharma Ab | New combination of pemirolast and montelukast |
| JP6749343B2 (ja) * | 2015-05-20 | 2020-09-02 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 脊髄性筋萎縮症を処置するための化合物 |
| EP4249472A3 (en) | 2015-05-30 | 2023-12-13 | PTC Therapeutics, Inc. | Methods for modulating rna splicing |
| GB201518831D0 (en) | 2015-10-23 | 2015-12-09 | Rspr Pharma Ab | New use |
| MX2021001091A (es) | 2015-12-10 | 2022-04-26 | Ptc Therapeutics Inc | Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington. |
| GB201601138D0 (en) * | 2016-01-21 | 2016-03-09 | Rspr Pharma Ab | New use |
| EA201991309A1 (ru) | 2016-11-28 | 2019-11-29 | Способы модуляции сплайсинга рнк | |
| EP3634953B1 (en) | 2017-06-05 | 2024-01-03 | PTC Therapeutics, Inc. | Compounds for treating huntington's disease |
| JP2020523365A (ja) | 2017-06-14 | 2020-08-06 | ピーティーシー セラピューティクス，インコーポレーテッド | Ｒｎａスプライシングを改変する方法 |
| MX2019015580A (es) | 2017-06-28 | 2020-07-28 | Ptc Therapeutics Inc | Metodos para tratar la enfermedad de huntington. |
| BR112019027717A2 (pt) | 2017-06-28 | 2020-07-28 | Ptc Therapeutics, Inc. | métodos para tratar a doença de huntington |
| CA3094703A1 (en) | 2018-03-27 | 2019-10-03 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
| EP3814357B1 (en) | 2018-06-27 | 2024-05-01 | PTC Therapeutics, Inc. | Heterocyclic and heteroaryl compounds for treating huntington's disease |
| EP3814360A1 (en) | 2018-06-27 | 2021-05-05 | PTC Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3072485A (en) * | 1960-08-24 | 1963-01-08 | Eastman Kodak Co | Optically sensitized azido polymers for photomechanical resist compositions |
| CH538494A (de) * | 1966-11-02 | 1973-06-30 | Chinoin Gyogyszer Es Vegyeszet | Verfahren zur Herstellung neuer Homopyrimidazol-Derivate |
| US3960847A (en) * | 1972-04-17 | 1976-06-01 | E. R. Squibb & Sons, Inc. | 9-Substituted-4-oxopyrido(1,2-α)pyrimidine-3-carboxylic acids and derivatives thereof |
| US3929787A (en) * | 1974-04-22 | 1975-12-30 | Squibb & Sons Inc | 6,7,8,9-Tetrahydro-pyrido(1,2-a)pyrimidin-4-ones |
| US3960863A (en) * | 1974-06-25 | 1976-06-01 | Sankyo Company Limited | Pyrido[1,2-a]pyrimidinone derivatives |
| US4017625A (en) * | 1975-08-01 | 1977-04-12 | Pfizer Inc. | Anti-allergic N-(5-tetrazolyl)-1-oxo-1H-6-alkoxypyrimido-[1,2-a]quinoline-2-carboxamides and intermediates therefor |
| US4012387A (en) * | 1975-09-18 | 1977-03-15 | Warner-Lambert Company | Benzo-[g]pyrido[2,1-b]quinazolinones |
-
1977
- 1977-05-25 US US05/800,264 patent/US4122274A/en not_active Expired - Lifetime
-
1978
- 1978-05-15 GR GR56238A patent/GR71887B/el unknown
- 1978-05-17 ZA ZA00782816A patent/ZA782816B/xx unknown
- 1978-05-19 CA CA303,794A patent/CA1098520A/en not_active Expired
- 1978-05-19 BE BE187888A patent/BE867295A/xx not_active IP Right Cessation
- 1978-05-22 FI FI781614A patent/FI64594C/fi not_active IP Right Cessation
- 1978-05-22 NL NL7805534A patent/NL190702C/xx not_active IP Right Cessation
- 1978-05-22 AU AU36319/78A patent/AU521211B2/en not_active Expired
- 1978-05-23 AT AT0373278A patent/AT365187B/de not_active IP Right Cessation
- 1978-05-23 DK DK228878A patent/DK160279C/da active
- 1978-05-23 LU LU79694A patent/LU79694A1/xx unknown
- 1978-05-23 DE DE19782822544 patent/DE2822544A1/de active Granted
- 1978-05-23 NO NO781786A patent/NO150361C/no unknown
- 1978-05-24 SE SE7805954A patent/SE437830B/sv not_active IP Right Cessation
- 1978-05-24 GB GB22090/78A patent/GB1596476A/en not_active Expired
- 1978-05-24 YU YU1236/78A patent/YU42163B/xx unknown
- 1978-05-24 CY CY1218A patent/CY1218A/xx unknown
- 1978-05-24 IT IT49523/78A patent/IT1105040B/it active
- 1978-05-24 FR FR7815398A patent/FR2401159A1/fr active Granted
- 1978-05-24 IE IE1036/78A patent/IE46849B1/en not_active IP Right Cessation
- 1978-05-25 CH CH572378A patent/CH642656A5/de not_active IP Right Cessation
- 1978-05-25 JP JP53061768A patent/JPS6050197B2/ja not_active Expired
-
1982
- 1982-10-15 YU YU2330/82A patent/YU44212B/xx unknown
-
1983
- 1983-11-25 SG SG733/83A patent/SG73383G/en unknown
- 1983-12-15 KE KE3357A patent/KE3357A/xx unknown
-
1984
- 1984-03-22 HK HK258/84A patent/HK25884A/xx not_active IP Right Cessation
-
1985
- 1985-12-30 MY MY305/85A patent/MY8500305A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU79694A1 (fr) | Procede de preparation de 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidine-4-ones | |
| PT68573A (fr) | Procede de preparation des derivatifs d'imidazole. | |
| BE873136A (fr) | Procede de preparation de la vincadifformine | |
| FR2397412B1 (fr) | Procede de preparation de thioxanthones eventuellement substituees | |
| BE866839A (fr) | Procede de preparation de triazines 1,3,5-s-hexahydrotrisubstituees | |
| LU80576A1 (fr) | Procede de preparation de nouvelles indolo(2,3-a)quinolizidines | |
| AR229519A1 (es) | Procedimiento de preparacion de derivados de 2,3-dihidro-9-fenil-1h-pirazolo(1,2-a)-indazolio | |
| FR2335522A1 (fr) | Procede de preparation d'androstene-4 diones-3,17 | |
| BE843199A (fr) | Procede de preparation de 2,4-dioxo-1,2,3,4-tetrahydro-s-triazino-(1,2-a)-benzimidazoles | |
| AR218498A1 (es) | Procedimiento de preparacion de derivados de 1,3-difenoxipropan-2-ona | |
| PT68991A (fr) | Procede de preparation de derives de thiazolidinedione-2,4 | |
| NO801342L (no) | Fremgangsmaate for fremstilling av substituerte pyrido (1,2-a) pyrimidiner. | |
| PT67958A (fr) | Procede de preparation de derives de pyridazinone. | |
| LU78874A1 (fr) | Procede de preparation de nouvelles sulfonylhydrazones de 1,4-dioxo-et 4-oxoquinoxaline-2-carboxaldehyde | |
| FI782517A (fi) | Foerfarande foer framstaellning av 2,3-polymetylen-4-oxo-4h-pyrido(1,2-a)-pyrimidiner | |
| NL7803112A (nl) | Werkwijze voor de bereiding van nieuwe pyrido (2.1-b)chinazolinederivaten. | |
| BE866662A (fr) | Procede de preparation de 3,5-dihalogenanilines | |
| ES491153A0 (es) | Procedimiento de preparar derivados pirrolo(1,2-a)pirimidi- nicos | |
| FR2319615A1 (fr) | Procede de preparation de cyclohexane-diones-1,3 | |
| FR2312497A1 (fr) | Procede de preparation de 5-(2,2-dihalogenovinyl)-4,4-dimethyl-2-oxotetrahydrofurannes | |
| ES491732A0 (es) | Procedimiento de preparacion de monohidrato de 1,25-dihidro-xi-colecalciferol | |
| BE870104A (fr) | Procede de preparation de 2-chlorosulfinyl-azetidin-4-ones | |
| AR220228A1 (es) | Procedimiento para la preparacion de derivados de tiazin-1,3-(3,4-b)-isoquinoleina | |
| PT67685A (fr) | Procede de preparation de derives 17 alpha-acetyleniques de l'androst-4-ene | |
| PT72246A (fr) | Procede de preparation catalytique de la tieno /3,2-c/pyridine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DT | Application date | ||
| TA | Annual fee |